These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 15207760

  • 1. Effects of discontinuation as well as intervention of cyclic therapy with etidronate on bone remodeling after cementless total hip arthroplasty.
    Yamaguchi K, Masuhara K, Yamasaki S, Fuji T, Seino Y.
    Bone; 2004 Jul; 35(1):217-23. PubMed ID: 15207760
    [Abstract] [Full Text] [Related]

  • 2. Etidronate does not suppress periprosthetic bone loss following cemented hip arthroplasty.
    Fokter SK, Komadina R, Repse-Fokter A, Yerby SA, Kocijancic A, Marc J.
    Int Orthop; 2005 Dec; 29(6):362-7. PubMed ID: 16193347
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pattern of periprosthetic bone remodeling around stable uncemented tapered hip stems: a prospective 84-month follow-up study and a median 156-month cross-sectional study with DXA.
    Aldinger PR, Sabo D, Pritsch M, Thomsen M, Mau H, Ewerbeck V, Breusch SJ.
    Calcif Tissue Int; 2003 Aug; 73(2):115-21. PubMed ID: 14565592
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The clinical benefits to bone mineral density were shown by cyclical oral etidronate administration in steroid induced osteoporosis].
    Nakamura T, Maekawa S, Morinobu S, Morinobu A, Koshiba M, Yamauchi M, Sugimoto T, Kumagai S.
    Ryumachi; 2002 Aug; 42(4):666-75. PubMed ID: 12355861
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Changes in bone mineral density (BMD) around the cemented Exeter stem: a prospective study in 18 women with 5 years follow-up.
    Damborg F, Nissen N, Jørgensen HR, Abrahamsen B, Brixen K.
    Acta Orthop; 2008 Aug; 79(4):494-8. PubMed ID: 18766482
    [Abstract] [Full Text] [Related]

  • 11. [Effect of alendronate on periprosthetic bone loss after cemented primary total hip arthroplasty: a prospective randomized study].
    Nehme A, Maalouf G, Tricoire JL, Giordano G, Chiron P, Puget J.
    Rev Chir Orthop Reparatrice Appar Mot; 2003 Nov; 89(7):593-8. PubMed ID: 14699304
    [Abstract] [Full Text] [Related]

  • 12. Effect of intermittent cyclical etidronate therapy on corticosteroid induced osteoporosis in Japanese patients with connective tissue disease: 3 year followup.
    Sato S, Ohosone Y, Suwa A, Yasuoka H, Nojima T, Fujii T, Kuwana M, Nakamura K, Mimori T, Hirakata M.
    J Rheumatol; 2003 Dec; 30(12):2673-9. PubMed ID: 14719212
    [Abstract] [Full Text] [Related]

  • 13. Effect of etidronate in preventing periprosthetic bone loss following cemented hip arthroplasty: a randomized, double blind, controlled trial.
    Fokter SK, Komadina R, Repse-Fokter A.
    Wien Klin Wochenschr; 2006 Dec; 118 Suppl 2():23-8. PubMed ID: 16817039
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of different dosing schedules of etidronate for stress shielding after cementless total hip arthroplasty.
    Yamaguchi K, Masuhara K, Yamasaki S, Fuji T.
    J Orthop Sci; 2005 Dec; 10(1):32-6. PubMed ID: 15666120
    [Abstract] [Full Text] [Related]

  • 15. Changes in the bone mineral density in the acetabulum and proximal femur after cementless total hip replacement: alumina-on-alumina versus alumina-on-polyethylene articulation.
    Kim YH, Yoon SH, Kim JS.
    J Bone Joint Surg Br; 2007 Feb; 89(2):174-9. PubMed ID: 17322430
    [Abstract] [Full Text] [Related]

  • 16. Risedronate reduces postoperative bone resorption after cementless total hip arthroplasty.
    Yamasaki S, Masuhara K, Yamaguchi K, Nakai T, Fuji T, Seino Y.
    Osteoporos Int; 2007 Jul; 18(7):1009-15. PubMed ID: 17554581
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty: a prospective randomized study.
    Venesmaa PK, Kröger HP, Miettinen HJ, Jurvelin JS, Suomalainen OT, Alhav EM.
    J Bone Miner Res; 2001 Nov; 16(11):2126-31. PubMed ID: 11697810
    [Abstract] [Full Text] [Related]

  • 19. 36 month intermittent cyclical etidronate treatment in patients with established corticosteroid induced osteoporosis.
    Sebaldt RJ, Ioannidis G, Adachi JD, Bensen WG, Bianchi F, Cividino A, Gordon M, Kaminska E, Scocchia T, Petrie A, Stephenson GF, Goldsmith CH.
    J Rheumatol; 1999 Jul; 26(7):1545-9. PubMed ID: 10405943
    [Abstract] [Full Text] [Related]

  • 20. Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis.
    Struys A, Snelder AA, Mulder H.
    Am J Med; 1995 Sep; 99(3):235-42. PubMed ID: 7653482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.